Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Identifying warning signs of poor retirement planning is essential for financial health. Learn how to act now for a more secure retirement.
15,260 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Brad Reese, heir to the Reese’s legacy, alleges Hershey’s has shifted core ingredients in Reese’s cups. Hershey says ...
Stocks wiggle as CoreWeave drops on news of Blue Owl’s failed $4B debt placement. Experts say the financing hiccup co...
Rocket Lab is shaping the small-launch landscape, and the company’s 2025 earnings story matters for investors. This g...
Ethereum faces near-term headwinds, but a rebound may follow a deeper pullback. This analysis translates Standard Cha...
On Mar. 5, Nvidia nudges higher as investors weigh AI data-center spending and long-term earnings prospects. This sto...
Oracle’s $523 billion backlog raises timing concerns as capex surges. cnbc’s deirdre bosa warns that the chip upgrade...
Alibaba’s AI projects a bullish path for XRP, Bitcoin and Ethereum by late 2026, even as regulators refine crypto rul...
As the S&P 500 retreats, two growth-focused ETFs show resilience. This report breaks down why FELG and QQQ are defyin...
Looking to ride a big move in a small-cap space? Learn how to spot a small-cap growth stock before it hits its next e...
Kharg Island, a key Iran oil export hub, is under the spotlight as geopolitical tensions heighten risk to energy flow...
A close look at tapestry (tpr) 2026 earnings reveals what drives revenue, margins, and stock performance. Learn how t...